Find out about the latest news and developments from C3 BIOTECH
Successful RAF trial of our synthetic fuel
C3 BIOTECH is proud to be working with the UK RAF and US Navy to develop synthetic aviation fuel. In an international collaboration between UK and US, our fuel was successfully used by the RAF to fly a four-meter drone. The initial trial created 15 litres of fuel in laboratory conditions. Following successful engine testing, the fixed-wing drone completed a 20-minute test flight in Wiltshire, providing valuable data that indicates the fuel performs consistently to a high standard. This project is now in the next phase with work underway to refine the process and develop deployable manufacturing facilities.
Advances in Bio-LPG
Some of our earlier research into BIO-LPG production has recently been published in two peer reviewed articles. The studies, conducted in collaboration with colleagues at The University of Manchester, highlight methods for the production of bio-alkane gas (propane and butane) through the conversion of waste volatile fatty acids by bacterial culture, and new microbial pathways for the production of clean-burning BIO-LPG fuels from amino acids derived from waste streams. The full publications can be viewed here:
- Low carbon strategies for sustainable bio-alkane gas production and renewable energy
- Renewable and tuneable bio-LPG blends derived from amino acids
Biomanufacturing: A Path to Sustainable Economic Recovery
C3 BIOTECH’s ‘fuel from waste’ programme was highlighted in a recent spotlight edition of the New Statesman.
In the article, C3 BIOTECH’s Scientific Director, Professor Nigel Scrutton, outlined the green potential of biotechnologies. The article, which was entitled ‘Biomanufacturing: a path to sustainable economic recovery’ can be viewed here.
C3 BIOTECH Head of Science Elected as Fellow of the Royal Society
C3 BIOTECH is pleased to announce that our Founding Partner and Head of Science, Professor Nigel Scrutton, has been elected as a Fellow of the Royal Society. See Royal Society announcement for more detail.
We are very proud, and justifiably delighted, that this most prestigious of appointments has been granted to our own Senior Scientific Officer. It is magnificent testimony to his long term dedication and world leading scientific skills, which have established cutting edge industrial biotechnologies that are creating solutions to global energy production and waste management problems.
Our warmest congratulations go out to Professor Scrutton FRS ScD FRSC FRSB
MIB Awarded Queen’s Anniversary Prize
As a spin out Company of the Manchester Institute of Biotechnology (MIB), C3 BIOTECH is proud to recognise the achievement of the MIB in being awarded today (21 November 2019) a Queen’s Anniversary Prize (2018-2020).
C3 BIOTECH recognises the unique environment of the MIB and the close working partnerships it develops with wide ranging industries (corporates to SMEs). C3 BIOTECH is pleased and proud to be working with the MIB in the ‘fuels from biology’ area and we congratulate the Institute and celebrate it’s success in securing this most prestigious award.
Read more at: Queen’s Anniversary Prize Awarded to MIB
ADVANCED SYNTHETIC FUELS
C3 BIOTECH has partnered with a US Centre to develop bio-based production routes for aviation fuel precursors at scale.
Through its Visiting Scientists Program and Research Grants, ONR-Global has funded researchers from C3 BIOTECH Ltd/The University of Manchester, in a coordinated effort with the United Kingdom’s Defence Science and Technology Laboratory (DSTL), to develop biosynthetic routes to important aviation precursors.
As the commercial partner, C3 BIOTECH is tasked with developing scaled manufacturing pathways for aviation fuel.
HIGH VALUE CHEMICALS
Many waste streams from industrial and agricultural production in developing countries are being left completely underutilised and ultimately create substantial ongoing problems from the inevitable pollution they leave behind.
C3 BIOTECH’s recent Waste to Wealth project in India (which is being co-sponsored with support from the BBSRC, Innovate UK and the Newton Bhabha fund) has been set up to develop industrial processes to create high value chemicals from paper mill waste.
C3 BIOTECH is constantly working to develop new metabolic pathways and organisms which have important roles to play in turning problematic, low value waste streams into high value chemical materials using natural biological processes. These techniques avoid using existing expensive and ‘dirty’ conventional chemical engineering processes, thus generating significant added value to the economic prosperity of a nation while at the same time reducing the impact of industrial wastes upon the global environment.